New diabetes pill shows promise in year-long safety trial
NCT ID NCT02314637
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study tested the safety and effectiveness of the drug MP-513 (Teneligliptin) in 240 Japanese adults with type 2 diabetes. Some took MP-513 alone, others combined it with the older drug glimepiride. Over 52 weeks, researchers tracked side effects and measured blood sugar control. The goal was to see if MP-513 is a safe long-term option for managing diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Shikoku, Japan
Conditions
Explore the condition pages connected to this study.